Dr. A. Mark Fendrick, Director of the Center for Value-Based Insurance Design (V-BID), recently traveled to mainland China to present at the Chinese Economic Society's Roundtable Discussion on precision medicine, the China-US Precision Medicine Industry and Policy Forum, and Beijing Hospital. For more information about each of these events, please follow the links below. Dr. Fendrick addressing the Chinese Economic Society about key tenets of V-BID strategy.
On Thursday, June 16, V-BID Center Director, Dr. A. Mark Fendrick, will present at Beijing Hospital in China. His presentation is titled "Value-Based Insurance Design: How to Improve Health and Be Able to Afford It." Dr. Fendrick's slide presentation is available via the link below: Dr. Fendrick with Dr. Sang Zhicheng of Beijing Hospital
On Monday, June 13th, Dr. A. Mark Fendrick, Director of the Center for Value-Based Insurance Design (V-BID), spoke at the China-US Precision Medicine Industry and Policy Forum. The Forum is part of a larger event, titled "The Fourth Shenzhen International Low Carbon City Forum," and took place in Shenzhen, Guangdong Province, China. Dr. Fendrick also participated in an additional roundtable event held on Sunday, June 12th. The event will bring together health economists and policy stakeholders to discuss the opportunities and challenges of using genomic science to improve the quality and efficiency of health care and public health services delivery in China and internationally. Dr. Fendrick will discuss V-BID in the context of the Chinese health system and precision medicine. Dr. Fendrick's presentation, including the Chinese translation, can be found below. Dr. Fendrick presenting about the key tenets of V-BID strategy in China. [...]
Access to prescription drugs is a hot-button health care issue. The V-BID center proposes an innovative benefit design - 'Reward the Good Soldier'.
This month's news update features a timeline outlining V-BID's history, a new video introducing a novel benefit design, and publications that support V-BID programs.
On Monday, April 4, Health Affairs reported that one state's Value-Based Insurance Design employee insurance program, which was designed to improve health while reducing costs, has successfully encouraged more use of screenings and preventive services, increased medication adherence for chronic conditions, and reduced visits to the emergency department.Researchers from the V-BID Center say, not unexpectedly, that it's too early to tell after two years of study if Connecticut's Health Enhancement Program has saved the state money.Their findings are reported in the April edition of Health Affairs. The Health Affairs article and related materials can be found below. Health Affairs Article IHPI Press Release HEP Infographic
On Tuesday, March 8th, the Centers for Medicare and Medicaid Services (CMS) proposed a rule that would test a new way for Medicare Part B to pay for prescription drugs. The proposal includes value-based insurance design (V-BID) principles of discounting or eliminating cost-sharing and varying payments for drugs based on clinical effectiveness for different indicators (clinical nuance). CMS Acting Administrator Andy Slavitt stated, "These proposals would allow us to test different ways to help Medicare beneficiaries get the right medications and right care while supporting physicians in the process. This is consistent with our focus on testing value-based care models like we have been doing with physicians and hospitals in ACOs. Models like this one can help doctors and other clinicians do what they do best: choose the medicine and treatment that keeps their patients healthy." Read more on V-BID in the Medicare program.
Dr. Mark Fendrick discusses how the Geisinger V-BID Program leads to savings by eliminating drug co-payments A study published in the February 2016 issue of The American Journal of Managed Care investigated the potential cost-savings of a $0 prescription co-pay program for chronically ill employees of the Geisinger Health System (GHS). Approximately 200 anti-hypertensive, anti-diabetic, and anti-lipid medications were provided at zero cost-sharing to 2251 GHS employees as part of an employee health and wellness program. The program showed positive cost-savings and a positive 5-year return on investment.
On Tuesday, February 23rd, 2016, Dr. A. Mark Fendrick, V-BID Center Director, testified before the United States Senate Committee on Armed Services Subcommittee on Personnel. Dr. Fendrick discussed how the principles of value-based insurance design (V-BID) and clinical nuance can contribute positively to defense health care reform.The hearing announcement and testimony materials are available below:
2018 V-BID Summit Sponsorship Opportunities The 2018 V-BID Summit will be held as a two-day event at the University of Michigan on March 13/14. The Summit invites stakeholders to engage in a highly interactive all-day discussion to address the opportunities and challenges that arise from the conceptual design to the implementation of clinically nuanced payment reform and benefit design strategies across some of today’s most relevant and challenging health care topics. A draft agenda will soon be available for dissemination. All donations/sponsorships will be gratefully accepted, including amounts lower and higher than those listed below. Special consideration will be given to non-profit organizations. For more information, please contact Susan Lynne Oesterle at 734-615-9635 or sloester@umich.edu. Platinum sponsorship includes six invitations to the following: V-BID Summit evening reception Evening welcome dinner Networking breakfast Summit discussions Networking lunch Platinum sponsorship recognition includes: Full [...]
On Tuesday, February 9th, Dr. A. Mark Fendrick, V-BID Center Director, testified before the Michigan Senate Appropriations Subcommittee on Health and Human Services in Lansing, Michigan. Dr. Fendrick discussed opportunities to improve the health of Michigan residents through the utilization of value-based services and performance metrics, as well as how clinically nuanced cost-sharing has been an effective way to improve value and creates an opportunity for broad innovation in the Medicaid space. Value-based insurance design (V-BID) principles are included in the Healthy Michigan Plan for Medicaid expansion, as outlined in the V-BID Center's Michigan Medicaid brief. The Hearing announcement can be accessed here. More Hearing materials are available below: Presentation Slides AJMC Clinical Nuance Infographic
On October 6/7, 2015, the University of Michigan Center for Value-Based Insurance Design held its 10th Anniversary V-BID Summit entitled: A Decade of Transforming the Health Care Cost Discussion from ‘How Much’ to ‘How Well.’
This interactive timeline highlights the numerous V-BID achievements in 2015. From the passing of legislation, to the announcement of a V-BID demonstration in Medicare Advantage, to a 10th Anniversary V-BID Summit, 2015 was a standout year for V-BID.
"Improving Consumers' Access to High-Value Health Care: Value-Based Insurance Design and alignment with delivery system reform" Senate Briefing Details SD-G11 Dirksen Senate Office Building Tuesday, July 21st 10:00 AM- 11:00 AM (Continental breakfast available at 9:45) RSVP to: Arielle Zina at azina@smarterhc.org Senate Briefing Invitation House Briefing Details 1539 Longworth House Office Building Tuesday, July 21st 2:30 PM- 3:30 PM (Light lunch and appetizers available at 2:15) RSVP to: Arielle Zina at azina@smarterhc.org House Briefing Invitation V-BID Materials MA Materials HDHP Materials
